AEON Biopharma (AEON) Other financing activities (2021)

AEON Biopharma (AEON) posted Other financing activities of -$100000.0 for Q4 2021, down 200.0% sequentially from $100000.0 in Q2 2021.

AEON Biopharma (AEON) Other financing activities (2021) Analysis & Trends

AEON Biopharma has reported Other financing activities for 1 years, with the latest figure at -$100000.0 in Q4 2021.

Quarterly Other financing activities changed N/A year-over-year to -$100000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $7.8 million (changed N/A YoY) and the FY2025 annual result came in at $18.3 million, changed N/A from the prior year.
Other financing activities fell to -$100000.0 in Q4 2021 per AEON's latest filing, from $100000.0 in the prior quarter.
Over five years, Other financing activities peaked at $7.8 million in Q1 2021 and troughed at -$100000.0 in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	140.52 Bn	132.67 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.54 Bn	78.55 Bn	3.93 Bn
3	Argenx Se	65.31 Bn	60.13 Bn	1.37 Bn
4	Moderna	61.77 Bn	56.64 Bn	52.00 Mn
5	BeOne Medicines	42.26 Bn	37.16 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.19 Bn	27.88 Bn	992.69 Mn
7	BioNTech SE	28.71 Bn	10.31 Bn	668.28 Mn
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn
9	Royalty Pharma	27.35 Bn	26.52 Bn	-
10	AEON Biopharma	9.85 Mn	6.42 Mn	-

Download Data